Brokerages Set GSK plc (LON:GSK) Price Target at GBX 1,805.83

Shares of GSK plc (LON:GSK) have been assigned a consensus rating of “Moderate Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is GBX 1,805.83 ($22.63).

Several analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 1,850 ($23.18) target price on shares of GSK in a research note on Tuesday, September 3rd. Berenberg Bank reduced their price objective on shares of GSK from GBX 1,820 ($22.81) to GBX 1,600 ($20.05) and set a “buy” rating on the stock in a research report on Friday, November 29th. Finally, JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a research report on Wednesday, December 11th.

Insiders Place Their Bets

In other news, insider Jonathan Symonds acquired 1,500 shares of the business’s stock in a transaction on Friday, December 20th. The shares were acquired at an average price of GBX 1,315 ($16.48) per share, for a total transaction of £19,725 ($24,718.05). Insiders have purchased 8,658 shares of company stock valued at $11,950,792 over the last ninety days. 1.61% of the stock is owned by insiders.

GSK Trading Up 0.1 %

Shares of GSK stock opened at GBX 1,340.50 ($16.80) on Friday. GSK has a fifty-two week low of GBX 1,282.50 ($16.07) and a fifty-two week high of GBX 1,823.50 ($22.85). The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. The company has a market capitalization of £54.69 billion, a P/E ratio of 1,186.28, a P/E/G ratio of 1.24 and a beta of 0.31. The company has a fifty day moving average of GBX 1,376.50 and a 200 day moving average of GBX 1,499.32.

GSK Dividend Announcement

The firm also recently declared a dividend, which will be paid on Thursday, January 9th. Investors of record on Thursday, November 14th will be issued a GBX 15 ($0.19) dividend. This represents a dividend yield of 1.03%. The ex-dividend date is Thursday, November 14th. GSK’s payout ratio is 5,309.73%.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.